Breakpoints

123 Episodo

1. #43 – Level Up: Implementation of Beta-lactam Therapeutic Drug Monitoring

   Publicado: 27/8/2021
2. #42 – The Level is in the Details: Beta-lactam Therapeutic Drug Monitoring

   Publicado: 20/8/2021
3. #41 – The Gray Zone: Antimicrobial Stewardship in Immunocompromised Hosts

   Publicado: 16/7/2021
4. #40 – Breakpoints Talks Breakpoints: Microbiology Labs and Stewardship

   Publicado: 18/6/2021
5. #39 – A Little More on the Littles: What Adults Should Know about ID Pediatrics

   Publicado: 21/5/2021
6. #38 – You're KID-ding! Myths in ID Pediatrics

   Publicado: 23/4/2021
7. #37 – A Gab about Cab: The Short on Long-Acting Antiretrovirals for HIV

   Publicado: 16/4/2021
8. #36 – Monoclonal Antibodies: Gateway Drugs for Future Care Delivery Models

   Publicado: 26/3/2021
9. #35 – Oral Beta-Lactams, Are We Serious?

   Publicado: 19/3/2021
10. #34 – The New Scoop on Poop: Updates in the Management of C. difficile infections

    Publicado: 19/2/2021
11. #33 – A Lung Time Coming: Controversies in Community Acquired Pneumonia

    Publicado: 15/1/2021
12. #32 – Unsolicited Advice: An Honest Discussion of Burnout in Stewardship

    Publicado: 18/12/2020
13. #31 – “Mind the Gap”: Antimicrobial Stewardship at Transitions of Care

    Publicado: 20/11/2020
14. #30 – Is More Better? The Role of Combination Therapy for MRSA

    Publicado: 9/10/2020
15. #29 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 2

    Publicado: 11/9/2020
16. #28 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 1

    Publicado: 4/9/2020
17. #27 – Expert Updates in Gram Negative Resistance: Q&A Session

    Publicado: 31/7/2020
18. #26 – OPAT - The Final Frontier, Part 2

    Publicado: 19/6/2020
19. #25 – Remdesivir: Ethical and Practical Considerations for Allocation, Tracking, and More

    Publicado: 18/6/2020
20. #24 – OPAT – The Final Frontier, Part 1

    Publicado: 12/6/2020